The company has achieved EBIDTA positive on a go-forward cash basis REDWOOD CITY, CA / ACCESSWIRE / October 3, 2024 / ...

Dr. Mignone's expert ENT approach brings innovative VivAer® nasal relief to New Jersey residents.ROBBINSVILLE, NJ / ...

IGC Pharma, Inc. (NYSE American:IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for ...

Dr. Wilson brings over two decades of private practice experience to Modern Foot & Ankle, with expertise in sports medicine, ...

A Delicious, Soy-Free Blend Supporting Muscle Growth, Recovery, and Overall WellnessOCALA, FL / ACCESSWIRE / October 3, 2024 ...

In the field of pharmaceutical marketing, artificial intelligence (AI) has already shown its potential to enable companies to ...

The Almac Group has today announced an £11m investment and the creation of over 100 new jobs to expand its global analytical ...

Opportunities for Collaboration Continue to Draw Independent Large and Small Practices From Across the CountryPUYALLUP, WA / ACCESSWIRE / October 3, 2024 / The newly established ONCare Alliance, which ...

CHARLOTTE, NC / ACCESSWIRE / October 3, 2024 / Epsom Salt Council, an organization dedicated to raising awareness about the health and wellness benefits of Epsom salt (magnesium sulfate), announces ...

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health Investors Enara Bio’s EDAPT® ...

Data from the study with the lead ADC candidate, HDP-101, show elimination of tumor cells in one patientClinical data from IMS will be presented in R&D webinar on 15 October at 17:00 CEST / 11:00 ...

Syncona’s £63.5 million Series B commitment will be used by Resolution to progress the company and advance its lead candidate, RTX001 in end-stage liver diseaseRTX001 is expected to enter the clinic ...